Stručni rad

Epitheloid Hemangioendothelioma in Patient with Liver Transplantation

Tajana Filipec Kanižaj ; Department of Medicine, University Hospital »Merkur«, Zagreb, Croatia
Vesna Čolić Cvrlje ; Department of Medicine, University Hospital »Merkur«, Zagreb, Croatia
Anna Mrzljak ; Department of Medicine, University Hospital »Merkur«, Zagreb, Croatia
Ika Kardum-Skelin ; Department of Medicine, University Hospital »Merkur«, Zagreb, Croatia
Dunja Šušterčić ; Department of Medicine, University Hospital »Merkur«, Zagreb, Croatia
Dinko Šegro ; Department of Medicine, University Hospital »Merkur«, Zagreb, Croatia
Denis Guštin ; Department of Anaesthesiology and Intensive Care, University Hospital »Merkur«, Zagreb, Croatia
Branislav Kocman ; Department of Surgery, University Hospital »Merkur«, Zagreb, Croatia

Sažetak

Malignant hepatic epithelioid hemangioendothelioma (HEH) is a rare malignant tumor of vascular origin with unknown aetiology and a variable natural course. At the time of diagnosis, most patients present with multifocal tumours lesions that involve both liver lobes. From the therapeutic aspect, liver resection (LRx), liver transplantation (LTx), chemotherapy, radiotherapy, and/or immunotherapy have been used in the treatment of patients with HEH. However, because of the rarity of this tumor and its unpredictable natural history, it is impossible to assess the effectiveness of these respective therapies. In this report, our objective was to present clinical aspects, diagnostic options, therapeutic modalities, and the clinical outcome of single patient with LTx because of this rare tumor.

Ključne riječi

hepatic epitheloid hemangioendothelioma; liver transplantation; fine needle aspiration cytology

Hrčak ID:

51260

URI

https://hrcak.srce.hr/51260

Datum izdavanja:

10.3.2010.

Posjeta: 1.576 *